Skip to main content
The muscle to
keep life moving®
We support all people, families and caregivers living with rare diseases, this Rare Disease Day and every day
2024 Rare Disease Day at Dyne

Trailblazing the development of
muscle-targeted therapies to stop or reverse disease progression—

Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.

cells

Our pioneering approach

Utilizing our proprietary FORCE™ platform to overcome limitations of muscle tissue delivery to advance modern oligonucleotide therapeutics

Learn more
muscle

Our pipeline

Developing a broad portfolio of therapies for muscle diseases

Learn more
commitment

Our commitment

Working to help fundamentally change the lives of people living with serious muscle diseases

Learn more
two females having conversation

Culture and careers

Our commitment to people living with serious muscle diseases is our greatest strength. Hear our Dynamos share their perspectives on what makes Dyne a special place to work.

Learn more

Latest news

January 10, 2025

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026

Read more

January 09, 2025

Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Read more
Rare Disease Day
AT DYNE WE SUPPORT ALL PEOPLE, FAMILIES AND CAREGIVERS LIVING WITH RARE DISEASES THIS RARE DISEASE DAY AND EVERY DAY
Rare Disease Day
The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.